81 related articles for article (PubMed ID: 27450163)
1. [Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system].
Aguirre C; García M
Med Clin (Barc); 2016 Nov; 147(10):461-464. PubMed ID: 27450163
[No Abstract] [Full Text] [Related]
2. Appeal for Increasing the Impact of Pharmacovigilance.
Kant AC
Drug Saf; 2024 Feb; 47(2):113-116. PubMed ID: 38114758
[No Abstract] [Full Text] [Related]
3. Predicting potential adverse events using safety data from marketed drugs.
Daluwatte C; Schotland P; Strauss DG; Burkhart KK; Racz R
BMC Bioinformatics; 2020 Apr; 21(1):163. PubMed ID: 32349656
[TBL] [Abstract][Full Text] [Related]
4. Pharmacovigilance: Basic concepts and an overview of the system in Oman.
Jose J; Al Rubaie MH; Al Ramimmy H; Varughese SS
Sultan Qaboos Univ Med J; 2021 May; 21(2):e161-e163. PubMed ID: 34221460
[No Abstract] [Full Text] [Related]
5. Letter to the Editor: A Discussion About Pharmacovigilance Study Methods.
Lee J
J Korean Med Sci; 2024 Apr; 39(15):e142. PubMed ID: 38651228
[No Abstract] [Full Text] [Related]
6. ALDRESS: A Retrospective Pilot Study to Develop a Pharmacological Causality Algorithm for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
Stewart S; Gómez López de Las Huertas A; Jiménez-González M; Carcas AJ; Borobia AM; Ramírez E
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731156
[No Abstract] [Full Text] [Related]
7. Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine.
Rodríguez-Lopez A; Mejía-Abril G; Zubiaur P; Calleja S; Román M; Abad-Santos F; Ochoa D
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256902
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific immune-mediated reactions to polyethylene glycol and polysorbate excipients: three case reports.
Rogozina O; Ruiz-Fernández C; Martín-López S; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
Front Pharmacol; 2023; 14():1293294. PubMed ID: 38235115
[TBL] [Abstract][Full Text] [Related]
9. Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide.
Soria-Chacartegui P; Zubiaur P; Ochoa D; Navares-Gómez M; Abbes H; Villapalos-García G; de Miguel A; González-Iglesias E; Rodríguez-Lopez A; Mejía-Abril G; Martín-Vilchez S; Luquero-Bueno S; Román M; Abad-Santos F
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894954
[TBL] [Abstract][Full Text] [Related]
10. Deletion of the
Facal F; Portela B; Gil-Rodríguez A; Barros F; Maroñas O; Carracedo A
Front Pharmacol; 2023; 14():1237446. PubMed ID: 37637419
[No Abstract] [Full Text] [Related]
11. Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions.
Rodríguez-Pérez R; de Las Vecillas L; Cabañas R; Bellón T
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628756
[TBL] [Abstract][Full Text] [Related]
12. Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system.
Filippi-Arriaga F; Aguilera C; Guillén E; Bellas L; Pérez E; Vendrell L; Agustí A; Cereza G
Front Pharmacol; 2023; 14():1211786. PubMed ID: 37492089
[No Abstract] [Full Text] [Related]
13. Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review.
Sans-Pola C; Danés I; Bosch JÀ; Marrero-Álvarez P; Cortés J; Agustí A
Front Med (Lausanne); 2023; 10():1159794. PubMed ID: 37305139
[TBL] [Abstract][Full Text] [Related]
14. Immune-Mediated Organ-Specific Reactions to COVID-19 Vaccines: A Retrospective Descriptive Study.
Ruiz-Fernández C; Cuesta R; Martín-López S; Guijarro J; López Gómez de Las Huertas A; Urroz M; Miguel-Berenguel L; González-Muñoz M; Ramírez E
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242502
[TBL] [Abstract][Full Text] [Related]
15. Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers.
Saiz-Rodríguez M; Ochoa D; Zubiaur P; Navares-Gómez M; Román M; Camargo-Mamani P; Luquero-Bueno S; Villapalos-García G; Alcaraz R; Mejía-Abril G; Santos-Mazo E; Abad-Santos F
J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983671
[TBL] [Abstract][Full Text] [Related]
16. Genetic Variation in
Soria-Chacartegui P; Zubiaur P; Ochoa D; Villapalos-García G; Román M; Matas M; Figueiredo-Tor L; Mejía-Abril G; Calleja S; de Miguel A; Navares-Gómez M; Martín-Vilchez S; Abad-Santos F
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839726
[TBL] [Abstract][Full Text] [Related]
17. Impact of polymorphisms in
Calleja S; Zubiaur P; Ochoa D; Villapalos-García G; Mejia-Abril G; Soria-Chacartegui P; Navares-Gómez M; de Miguel A; Román M; Martín-Vílchez S; Abad-Santos F
Front Pharmacol; 2023; 14():1110460. PubMed ID: 36817149
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline.
Zubiaur P; Matas M; Martín-Vílchez S; Soria-Chacartegui P; Villapalos-García G; Figueiredo-Tor L; Calleja S; Navares-Gómez M; de Miguel A; Novalbos J; Mejía-Abril G; Luquero-Bueno S; Román M; Ochoa D; Abad-Santos F
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297437
[TBL] [Abstract][Full Text] [Related]
19. Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice.
Sabaté Gallego M; Pérez Esquirol E; Garcia Doladé N; Vidal Guitart X; Carreras Soler MJ; Farriols Danés A; Felip E; Braña I; Carles Galceran J; Morales Barrera R; Muñoz-Couselo E; Agustí Escasany A
Front Med (Lausanne); 2022; 9():891179. PubMed ID: 36072949
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of Oniria
Román Martinez M; García Aguilar E; Martin Vílchez S; González García J; Luquero-Bueno S; Camargo-Mamani P; Mejia-Abril G; García-Castro L; de Miguel-Cáceres A; Saz-Leal P; Abad-Santos F; Nieto Magro C; Ochoa Mazarro D
Drugs R D; 2022 Sep; 22(3):235-243. PubMed ID: 35918587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
